Ligand Pharmaceuticals Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2016-03-31 3 months ending 2015-12-31 3 months ending 2015-09-30 3 months ending 2015-06-30 3 months ending 2015-03-31
Revenue 29.65 21.19 17.70 18.42 14.60
Other Revenue, Total - - - - -
Total Revenue 29.65 21.19 17.70 18.42 14.60
Cost of Revenue, Total 0.95 0.88 1.25 2.60 1.07
Gross Profit 28.69 20.31 16.45 15.82 13.53
Selling/General/Admin. Expenses, Total 6.83 6.19 4.97 7.22 5.99
Research & Development 4.00 2.87 2.54 4.01 3.96
Depreciation/Amortization 2.52 - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 0.24 0.23 0.34 -27.97 0.22
Other Operating Expenses, Total - - - - -
Total Operating Expense 14.55 10.18 9.10 -14.14 11.25
Operating Income 15.10 11.02 8.60 32.55 3.35
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net -0.92 -0.16 3.79 -6.42 -0.45
Income Before Tax 9.57 5.83 7.28 22.29 -0.07
Income After Tax 5.88 8.45 224.54 22.03 -0.09
Minority Interest 0.00 0.00 0.00 1.54 0.84
Equity In Affiliates - - - - -
Net Income Before Extra. Items 5.88 8.45 224.54 23.56 0.75
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income 6.61 8.45 224.54 23.56 0.75
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items 5.88 8.45 224.54 23.56 0.75
Income Available to Common Incl. Extra Items 6.61 8.45 224.54 23.56 0.75
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - - - 0.00
Diluted Weighted Average Shares 22.28 21.55 21.46 21.28 20.63
Diluted EPS Excluding Extraordinary Items 0.26 0.39 10.46 1.11 0.04
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 - 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS 0.27 0.40 10.47 0.25 0.04